Skip to main content
| News

World first in the Switzerland Innovation Park Basel Area

31.03.2022

Eldico Scientific has opened the world’s first experience center for electron diffractometry in the site Allschwil of the Switzerland Innovation Park Basel Area. The startup’s innovative device offers advanced nanoanalytic measurement results that have thus far been unattainable, among others for the pharmaceutical industry.

Measuring a sample in the electron diffractometer takes less than one minute (img: Eve Kaiser)

The world’s first experience center for electron diffractometry has started operation in Allschwil. The Switzerland Innovation Park Basel Area is the world’s first site of this new measurement instrument. It was developed by Eldico Scientific, a company founded in 2019 that is located at the Paul Scherrer Institute in Villigen, with which it collaborates closely.

According to a press release from Eldico, the Basel Area is “the right location” for the installation of the world’s first electron diffractometer due to the particularly high density of potential users. Its nanotechnology is implemented in the early phases of new drug development. It enables the spatial representation of molecules, showing the atomic structure of substances that are being investigated with regard to their suitability for medical development. However, the electron diffractometer is also useful for electromobility, specialty chemicals, and new materials.

Important clients with long-term contracts

To date, these visual representations have only been possible with x-ray technology or with an electron microscope. Both options are complex, slow, and expensive. Unlike an electron microscope, which is large and costs 4 million Swiss francs, the Eldico machine is priced at 1.8 million Swiss francs, is significantly smaller, and works much more quickly.

Among the clients with a long-term contract with the experience center in Allschwil is an academic-industrial consortium, consisting of RocheIdorsiaBoerhinger-Ingelheim from Germany, and the Swiss Nanoscience Institute of the University of Basel.

Dr. Christof Klöpper, CEO of the location promotion association Basel Area Business & Innovation, states: “This platform has huge potential to further enhance the life science innovation ecosystem in the region. This is why we are delighted that Eldico Scientific came to us with the idea and that we were able to support this initiative from the very start.” Basel Area Business & Innovation operates the Switzerland Innovation Park Basel Area.

Share this article

Sign up to receive our newsletter in your inbox.

You may also be interested in

Gamma Technologies acquires ProFEMAG portfolio
Advanced Manufacturing/AI, Basel Area Business & Innovation, ICT, Innovation, Invest

Gamma Technologies acquires ProFEMAG portfolio

The Basel-based firm ProFEMAG AG has sold its FEMAG software for electrical machine applications to Gamma Technologies. The company based...

Read More
Databaum establishes headquarters in Basel
Basel Area Business & Innovation, ICT, Innovation, Invest, Life Sciences / biotech

Databaum establishes headquarters in Basel

Databaum is establishing its headquarters in Basel and plans to grow from its location there. The startup provides the agricultural...

Read More
Clinerion launches patient information platform
Basel Area Business & Innovation, Digital Health, ICT, Innovation, Invest, Life Sciences / biotech

Clinerion launches patient information platform

Basel-based Clinerion is introducing its machine learning platform. It comprises a global network of hospitals and enables researchers to recognize...

Read More
New innovation campus opens in the Basel Area
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech, Switzerland Innovation Park

New innovation campus opens in the Basel Area

The Main Campus of the Switzerland Innovation Park Basel Area was officially opened on October 29. In his speech, Federal...

Read More
Sumitovant acquires all shares in Myovant
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Sumitovant acquires all shares in Myovant

Sumitovant is in the process of making Basel-based Myovant Sciences a wholly owned subsidiary by acquiring a 100 percent shareholding...

Read More
VectivBio raises 125 million US dollars in stock sale
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

VectivBio raises 125 million US dollars in stock sale

VectivBio has announced the closing of the subscription offer for 16,700,000 ordinary shares. The Basel-based biotechnology firm has generated gross...

Read More
1 2 3 29

Do you have a question? We'd like to hear from you.